Ikena Oncology Inc (IKNA)
1.71
-0.02
(-1.16%)
USD |
NASDAQ |
Nov 22, 16:00
1.69
-0.02
(-1.17%)
After-Hours: 20:00
Ikena Oncology Cash from Financing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | |
| December 31, 2023 | 0.06M |
| September 30, 2023 | 38.92M |
| June 30, 2023 | 37.00M |
| March 31, 2023 | |
| December 31, 2022 | 0.001M |
| September 30, 2022 | 0.024M |
| June 30, 2022 | 0.575M |
| Date | Value |
|---|---|
| March 31, 2022 | 0.495M |
| December 31, 2021 | 0.236M |
| September 30, 2021 | 0.069M |
| June 30, 2021 | -1.095M |
| March 31, 2021 | 132.53M |
| December 31, 2020 | 116.16M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.021M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.095M
Minimum
Jun 2021
132.53M
Maximum
Mar 2021
19.12M
Average
0.06M
Median
Dec 2023
Cash from Financing (Quarterly) Benchmarks
| MediciNova Inc | -- |
| NovaBay Pharmaceuticals Inc | 2.089M |
| Palatin Technologies Inc | -0.127M |
| iBio Inc | -0.162M |
| Theriva Biologics Inc | 3.716M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.938M |
| Cash from Investing (Quarterly) | 9.454M |
| Free Cash Flow | -61.56M |
| Free Cash Flow Per Share (Quarterly) | -0.1852 |
| Free Cash Flow Yield | -74.75% |